190 related articles for article (PubMed ID: 30122909)
1. Comparison between selected hormone and protein levels in serum and prostate tissue homogenates in men with benign prostatic hyperplasia and metabolic disorders.
Grzesiak K; Rył A; Baranowska-Bosiacka I; Rotter I; Dołęgowska B; Słojewski M; Sipak-Szmigiel O; Ratajczak W; Lubkowska A; Metryka E; Piasecka M; Laszczyńska M
Clin Interv Aging; 2018; 13():1375-1382. PubMed ID: 30122909
[TBL] [Abstract][Full Text] [Related]
2. Hormone concentration, metabolic disorders and immunoexpression of androgen and estrogen-alpha receptors in men with benign prostatic hyperplasia and testosterone deficiency syndrome.
Ryl A; Rotter I; Slojewski M; Dolegowska B; Grabowska M; Baranowska-Bosiacka I; Laszczynska M
Folia Histochem Cytobiol; 2015; 53(3):227-35. PubMed ID: 26400665
[TBL] [Abstract][Full Text] [Related]
3. Molecular Analysis of the SRD5A1 and SRD5A2 Genes in Patients with Benign Prostatic Hyperplasia with Regard to Metabolic Parameters and Selected Hormone Levels.
Rył A; Rotter I; Grzywacz A; Małecka I; Skonieczna-Żydecka K; Grzesiak K; Słojewski M; Szylińska A; Sipak-Szmigiel O; Piasecka M; Walczakiewicz K; Laszczyńska M
Int J Environ Res Public Health; 2017 Oct; 14(11):. PubMed ID: 29084161
[No Abstract] [Full Text] [Related]
4. Influence of metabolic syndrome on the relationship between fatty acids and the selected parameters in men with benign prostatic hyperplasia.
Grzesiak K; Rył A; Ratajczak W; Stachowska E; Rotter I; Słojewski M; Sipak O; Walczakiewicz K; Laszczyńska M
Aging (Albany NY); 2019 Mar; 11(5):1524-1536. PubMed ID: 30867336
[TBL] [Abstract][Full Text] [Related]
5. Relationship of serum sex-steroid hormones and prostate volume in African American men.
Joseph MA; Wei JT; Harlow SD; Cooney KA; Dunn RL; Jaffe CA; Montie JE; Schottenfeld D
Prostate; 2002 Dec; 53(4):322-9. PubMed ID: 12430143
[TBL] [Abstract][Full Text] [Related]
6. Age, genetic, and nongenetic factors influencing variation in serum sex steroids and zonal volumes of the prostate and benign prostatic hyperplasia in twins.
Meikle AW; Stephenson RA; Lewis CM; Wiebke GA; Middleton RG
Prostate; 1997 Oct; 33(2):105-11. PubMed ID: 9316651
[TBL] [Abstract][Full Text] [Related]
7. Serum concentrations of sex hormones in men with severe lower urinary tract symptoms and benign prostatic hyperplasia.
Tan MO; Karabiyik I; Uygur MC; Diker Y; Erol D
Int Urol Nephrol; 2003; 35(3):357-63. PubMed ID: 15160539
[TBL] [Abstract][Full Text] [Related]
8. Serum sex steroids, gonadotrophins and sex hormone-binding globulin in prostatic hyperplasia.
Ansari MA; Begum D; Islam F
Ann Saudi Med; 2008; 28(3):174-8. PubMed ID: 18500180
[TBL] [Abstract][Full Text] [Related]
9. Plasma estradiol, free testosterone, sex hormone binding globulin binding capacity, and prolactin in benign prostatic hyperplasia and prostatic cancer.
Rannikko S; Adlercreutz H
Prostate; 1983; 4(3):223-9. PubMed ID: 6189106
[TBL] [Abstract][Full Text] [Related]
10. Relationship between serum sex hormones levels and degree of benign prostate hyperplasia in Chinese aging men.
Zeng QS; Xu CL; Liu ZY; Wang HQ; Yang B; Xu WD; Jin TL; Wu CY; Huang G; Li Z; Wang B; Sun YH
Asian J Androl; 2012 Sep; 14(5):773-7. PubMed ID: 22751417
[TBL] [Abstract][Full Text] [Related]
11. Hormone blood levels and their inter-relationships in normal men and men with benign prostatic hyperplasia (BPH).
Bartsch W; Becker H; Pinkenburg FA; Krieg M
Acta Endocrinol (Copenh); 1979 Apr; 90(4):727-36. PubMed ID: 86267
[TBL] [Abstract][Full Text] [Related]
12. The Relationship between Eicosanoid Levels and Serum Levels of Metabolic and Hormonal Parameters Depending on the Presence of Metabolic Syndrome in Patients with Benign Prostatic Hyperplasia.
Grzesiak K; Rył A; Stachowska E; Słojewski M; Rotter I; Ratajczak W; Sipak O; Piasecka M; Dołęgowska B; Laszczyńska M
Int J Environ Res Public Health; 2019 Mar; 16(6):. PubMed ID: 30897712
[No Abstract] [Full Text] [Related]
13. Prospective study of sex hormone levels and risk of prostate cancer.
Gann PH; Hennekens CH; Ma J; Longcope C; Stampfer MJ
J Natl Cancer Inst; 1996 Aug; 88(16):1118-26. PubMed ID: 8757191
[TBL] [Abstract][Full Text] [Related]
14. Metabolic syndrome and benign prostatic hyperplasia: association or coincidence?
Rył A; Rotter I; Miazgowski T; Słojewski M; Dołęgowska B; Lubkowska A; Laszczyńska M
Diabetol Metab Syndr; 2015; 7():94. PubMed ID: 26516352
[TBL] [Abstract][Full Text] [Related]
15. Complex relationship between sex hormones, insulin resistance and leptin in men with and without prostatic disease.
Grosman H; Fabre B; Lopez M; Scorticati C; Lopez Silva M; Mesch V; Mazza O; Berg G
Aging Male; 2016; 19(1):40-5. PubMed ID: 26526283
[TBL] [Abstract][Full Text] [Related]
16. Low 25-OH vitamin D is associated with benign prostatic hyperplasia.
Haghsheno MA; Mellström D; Behre CJ; Damber JE; Johansson H; Karlsson M; Lorentzon M; Peeker R; Barret-Connor E; Waern E; Sundh V; Ohlsson C; Hammarsten J
J Urol; 2013 Aug; 190(2):608-14. PubMed ID: 23399651
[TBL] [Abstract][Full Text] [Related]
17. Serum steroid and sex hormone-binding globulin concentrations and the risk of incident benign prostatic hyperplasia: results from the prostate cancer prevention trial.
Kristal AR; Schenk JM; Song Y; Arnold KB; Neuhouser ML; Goodman PJ; Lin DW; Stanczyk FZ; Thompson IM
Am J Epidemiol; 2008 Dec; 168(12):1416-24. PubMed ID: 18945688
[TBL] [Abstract][Full Text] [Related]
18. Insulin-like growth factor 1 in relation to prostate cancer and benign prostatic hyperplasia.
Mantzoros CS; Tzonou A; Signorello LB; Stampfer M; Trichopoulos D; Adami HO
Br J Cancer; 1997; 76(9):1115-8. PubMed ID: 9365156
[TBL] [Abstract][Full Text] [Related]
19. Serum steroids in relation to benign prostatic hyperplasia.
Lagiou P; Mantzoros CS; Tzonou A; Signorello LB; Lipworth L; Trichopoulos D
Oncology; 1997; 54(6):497-501. PubMed ID: 9394847
[TBL] [Abstract][Full Text] [Related]
20. Cross-sectional association between testosterone, sex hormone-binding globulin and metabolic syndrome: The Healthy Twin Study.
Moon H; Choi I; Kim S; Ko H; Shin J; Lee K; Sung J; Song YM
Clin Endocrinol (Oxf); 2017 Nov; 87(5):523-531. PubMed ID: 28581026
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
